Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Oncolytics Biotech Inc. (ONCY)

-NasdaqCM

2.62 Down 0.10(3.68%) 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development31,538  22,968  13,971  
Selling General and Administrative5,308  5,239  6,042  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (36,846) (28,206) (20,014)
Income from Continuing Operations
Total Other Income/Expenses Net346  (278)(4,795)
Earnings Before Interest And Taxes(36,500)(28,485)(24,809)
Interest Expense -   -   -  
Income Before Tax(36,500)(28,485)(24,809)
Income Tax Expense31  39  8  
Minority Interest -   -   -  
Net Income From Continuing Ops(36,531)(28,524)(24,817)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (36,531) (28,524) (24,817)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (36,531) (28,524) (24,817)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.